OTC · SYUP
Anbc, Inc.
$0.00$0.00 (0.0%)
Anbc, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.0% below the high.
Loading market information…
OTC · IAGX · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Imagenetix, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Established in 1996 and headquartered in San Diego, California, Imagenetix, Inc. focuses on the creation, manufacturing, and distribution of distinctive, natural-ingredient nutritional supplements, as well as non-prescription topical creams and skincare solutions. Its flagship product, Celadrin, is a specialized formulation aimed at promoting joint well-being. The company also extends its business by licensing its proprietary technologies to third parties. Imagenetix reaches its customer base through a wide range of marketing avenues, encompassing direct and large-scale marketing enterprises, health and nutritional periodicals, medical and wellness professionals, and direct-response campaigns across radio and television.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:06 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Anbc, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.0% below the high.
$0.00$0.00 (0.0%)
Quick-Med Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 37.5% below the high.
$0.00$0.00 (0.0%)
Ventura Cannabis & Wellness Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Synovics Pharmaceuticals, Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
New Leaf Ventures Inc’s quoted price sits in the lower half of its reported 52-week range, 90.01% below the high.
$0.00$0.00 (0.0%)
BZAM Ltd.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00$0.00 (0.0%)
Neurobiological Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
CanaQuest Medical Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
